BPC-157 10mg · Research brief

Chemyo Review (2026): Testing, Catalog, Comparison

Real Peptides Research TeamEditorial

Updated October 14, 20269 min read

54 WORDS

Short answer

Most researchers typing 'is Chemyo legit' into a search bar are asking a sourcing question when what they actually have is a chemistry question. Chemyo built its name on SARMs, selective androgen receptor modulators, which are non-peptide small molecules, and anyone sourcing lyophilized peptides is standing in a different aisle of the same warehouse.

Key takeaways

Chemyo is an established research chemical vendor whose public catalog, as of October 2026, is built around SARMs and other non-peptide small molecules.
Publishing batch-linked third-party reports puts Chemyo ahead of vendors that publish nothing, but a certificate only counts when its batch identifier matches the container in hand.
HPLC purity and net peptide content measure different things, and only net peptide content states how much peptide a lyophilized vial actually holds.
Peptides degrade in aqueous solution through hydrolysis, oxidation and deamidation, which is why they ship as a dry cake rather than pre-dissolved.
Verifying a compound's CAS number and molecular identity before procurement is the cheapest quality control step available, whether the order goes to Chemyo or anywhere else.
Choosing between Chemyo and a peptide-first supplier is far more often a compound-class decision than a verdict on anyone's quality.

We synthesize and supply research peptides, so we assess other vendors the way we expect to be assessed: published third-party analysis, batch traceability, honest catalog labelling and handling discipline. This Chemyo review is nominative and independent, built from the company's own public pages as of October 2026. All products are sold for laboratory research use only and are not for human consumption.

Is Chemyo legit?

Chemyo is an established research chemical vendor that publishes third-party analytical reports tied to its product batches and labels its catalog research use only. As of October 2026, that catalog is built around SARMs and other small molecules rather than peptides, so a Chemyo review is most useful to researchers sourcing non-peptide compounds. Check the batch identifier before anything else.

Most Chemyo reviews online treat 'third-party tested' as a yes or no switch. It isn't one. A certificate of analysis carries weight only when it names the analytical method, carries a batch identifier matching the container in hand, and is recent enough to describe the material actually received. This Chemyo review covers what the catalog is built around, how to read the lab reports a vendor publishes, and where a SARMs-first operation and a peptide-first laboratory genuinely diverge.

What the catalog is actually built around

Chemyo's public catalog is dominated by non-peptide research chemicals, and that one fact decides whether the vendor is relevant to your work at all. SARMs such as RAD-140 (testolone), LGD-4033 (ligandrol) and MK-2866 (ostarine) are nonsteroidal small molecules designed to bind the androgen receptor with tissue-selective activity. Two of the compounds most often cross-listed beside them are not SARMs at all: GW-501516 (cardarine) is a PPAR-delta agonist, and MK-677 (ibutamoren) is a ghrelin receptor agonist that acts as a growth hormone secretagogue. Chemyo and its competitors group these together because buyers search for them together, not because they share a mechanism.

Peptides are a different chemical class: short chains of amino acids joined by peptide bonds, supplied as lyophilized powder because they are far less stable in solution than a small molecule is. Someone comparing Chemyo to a peptide supplier is not comparing two versions of the same product. They are comparing two manufacturing disciplines with different purity tests, different storage requirements and different ways of going wrong.

The regulatory framing deserves stating plainly. The U.S. Food and Drug Administration has publicly warned that SARMs are not approved for human use, and the World Anti-Doping Agency prohibits them on its anabolic agent list. Chemyo labels its products as research chemicals rather than supplements, which is the correct posture and genuinely not universal in this market. Our team treats that labelling as the baseline any Chemyo review should start from, not the finish line.

How to read a published certificate of analysis

A certificate of analysis is only as strong as three things printed on it: the method, the batch and the date. Chemyo publishes third-party analytical reports for its products, which already puts it ahead of the many vendors that publish nothing at all. The next step belongs to the buyer: open the report and confirm the batch identifier on the document matches the batch printed on the container received. A certificate with no batch number is a marketing asset, not a quality record.

Then read what was actually run. High-performance liquid chromatography (HPLC) reports purity as an area percentage of the chromatogram, describing how much of the detectable material is the main peak. Mass spectrometry confirms identity by measuring the mass-to-charge ratio of the molecule itself. Purity without identity is a clean sample of something unspecified. Identity without purity is the right molecule in poor company. Both, from the same batch, is the standard worth holding any vendor to, Chemyo included.

Here is the detail most buyers skip, and it matters far more for peptides than for anything on a Chemyo order form: chromatographic purity and net peptide content are not the same number. A lyophilized vial can read 99% pure by HPLC and still contain a meaningful fraction of water and residual counterions such as trifluoroacetate or acetate left behind during purification. Net peptide content, determined by amino acid analysis or nitrogen determination, states how much peptide is actually present. Small-molecule catalogs like Chemyo's never need that second figure. Peptide catalogs do.

Where a small-molecule vendor and a peptide laboratory diverge

The dividing line between these supplier types is stability, not sincerity. SARMs dissolved in a carrier solvent are comparatively robust at ambient temperature, which is exactly why a liquid format works commercially for a catalog like Chemyo's. Peptides behave differently. In aqueous solution they degrade through hydrolysis of the peptide backbone, oxidation of methionine and cysteine residues, and deamidation of asparagine and glutamine. Lyophilization strips out the water driving most of those reactions, which is why research peptides ship as a dry cake and are generally held at -20°C before reconstitution and between 2°C and 8°C afterwards.

Identity verification splits the same way. For a small molecule, a CAS registry number plus a mass spectrum settles the question. For a peptide, the sequence is the identity: BPC-157, CAS 137525-51-0, is a 15-amino-acid partial sequence of a protein found in gastric juice, and two vials carrying the same name with different sequences are two different compounds. Verifying a CAS number and molecular identity before procurement remains the cheapest quality control any laboratory can run.

That gap is why our own catalog is deliberately narrow. Real Peptides supplies small-batch synthesized research compounds with publicly verifiable certificates of analysis, including BPC-157 and TB-500, for laboratory research use only. Our team has worked with researchers who changed suppliers over cold chain handling alone, with purity figures never entering the conversation. A Chemyo-style operation is not built around that problem, and a fair Chemyo review should say so rather than score it as a failing.

Chemyo vs peptide-first suppliers: a methodology comparison

The useful question is not which vendor is better, but which methodology fits the compound class being sourced. The table sets the Chemyo approach, as described on the company's own public pages in October 2026, against a peptide-first laboratory workflow.

Evaluation criterion	SARMs-first vendor approach (Chemyo)	Peptide-first laboratory approach	Bottom line
Published analytical testing	Third-party HPLC and mass spectrometry reports posted per product batch on the public site	Third-party HPLC and mass spectrometry plus net peptide content for lyophilized material	Both publish documentation; only the peptide workflow answers how much peptide is in the vial
Catalog composition	Built around SARMs and adjacent small molecules such as GW-501516 and MK-677	Built around defined sequences such as BPC-157, TB-500 and growth hormone secretagogue peptides	Overlap is thin, so Chemyo versus a peptide lab is usually a compound-class decision, not a quality one
Product format and storage	Pre-dissolved liquid solutions in carrier solvent, stable at ambient temperature	Lyophilized powder held at -20°C before reconstitution and 2°C to 8°C afterwards	Liquid suits stable small molecules; dry format is non-negotiable for peptide integrity
Identity verification	CAS registry number and molecular mass confirmation	CAS number, molecular mass and amino acid sequence confirmation	Sequence verification has no small-molecule equivalent and cannot be substituted with purity data
Regulatory labelling	Research use only, not for human consumption, per the vendor's public product pages	Research use only, not for human consumption, with no therapeutic claims attached	Correct on both sides; any supplier implying human use should be disqualified outright

What If: vendor sourcing scenarios

What if the posted lab report has no batch number?

Treat the material as unverified until a batch-matched document is supplied. A certificate without a batch identifier describes some sample a laboratory once tested, not necessarily the container sitting on the bench. Vendors that index their reports by batch, Chemyo among them, make that link checkable in the first place. If a support request for the matching document goes unanswered, the silence is the answer.

What if a catalog lists peptides and small molecules side by side?

Read the storage specification for each product rather than the marketing description. Peptides and SARMs have incompatible handling requirements: one needs freezer storage and a cold shipping process, the other tolerates ambient transit. A single catalog can legitimately carry both, but cold chain detail is where a SARMs-first operation like Chemyo and a peptide-first laboratory become easy to tell apart. Where no storage temperatures are stated, assume no cold chain exists.

What if the compound arrives as a clear liquid instead of a dry cake?

Confirm the intended format on the product page before assuming an error occurred. Liquid solution is the standard commercial format for many stable small molecules and is exactly what a Chemyo-style catalog ships by design. A research peptide, by contrast, normally arrives as a lyophilized cake or powder under vacuum. A peptide delivered pre-dissolved raises stability questions that no certificate issued at the point of manufacture can answer.

What if the certificate of analysis is over a year old?

Ask for the testing date on that specific batch rather than on the compound generally. Analytical reports describe material at the moment it was tested, and degradation after that point is a function of time, temperature and formulation. For stable small molecules an older report ages gracefully. For peptides stored in uncontrolled conditions it ages badly, which is why batch-level date stamping matters more than any headline purity figure.

The unglamorous truth about vendor trust

Here's the honest answer: no published certificate proves the vial in front of you is what the label claims. It proves that a sample, on a date, tested a certain way. Every supplier in this space, Chemyo and Real Peptides alike, is asking a researcher to accept a chain of custody they did not personally witness. What separates a serious vendor from a careless one is how much of that chain is made inspectable: batch-level documents, named analytical methods, stated storage conditions, and a catalog that doesn't blur compound classes to catch extra search traffic. Chemyo does several of those things well. Verify them anyway.

Researchers comparing suppliers can review our published documentation in the certificate of analysis library, see what high-purity research material looks like on our pure peptides page, browse the full research catalog, or read our wider breakdown of peptide companies and how they test. Compounds such as Ipamorelin and CJC-1295 No DAC are supplied for laboratory research use only.

Judging Chemyo on whether it is legitimate skips past the more useful question, which is whether its methodology matches the molecule being studied. A liquid small-molecule catalog and a cold-chain peptide laboratory are solving different problems, and the vendor that solves one well has no obligation to solve the other. Decide the compound class first, then hold whichever supplier you choose to batch-level documentation and verifiable molecular identity. All products are sold for laboratory research use only and are not for human consumption. Real Peptides is not affiliated with Chemyo.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Chemyo is an established research chemical vendor that publishes third-party analytical reports for its product batches and labels its catalog as research use only, not for human consumption. That places it ahead of suppliers that publish no documentation at all. Legitimacy at the vendor level still does not remove the buyer's job of matching the batch identifier on the posted report to the batch printed on the container received.

As of October 2026, the Chemyo public catalog is built around SARMs and other non-peptide small molecules such as GW-501516 and MK-677 rather than peptide sequences. Researchers sourcing lyophilized peptides like BPC-157 or TB-500 are generally shopping a different supplier category, because peptides require cold storage, sequence confirmation and net peptide content reporting that small-molecule catalogs have no reason to provide.

Open the posted report and check three things: the analytical method named, the batch identifier, and the test date. The batch on the document must match the batch on the container in hand; a certificate with no batch number describes an unrelated sample. Confirm that both high-performance liquid chromatography for purity and mass spectrometry for molecular identity were run, since purity alone does not prove the molecule is the right one.

No. SARMs are nonsteroidal small molecules that bind the androgen receptor with tissue-selective activity, while peptides are short chains of amino acids joined by peptide bonds. The practical consequence is handling: SARMs stay comparatively stable dissolved in a carrier solvent at ambient temperature, whereas peptides hydrolyse, oxidise and deamidate in aqueous solution, which is why research peptides are supplied lyophilized and held cold.

Research chemicals of this type are sold for laboratory research use only and are not for human consumption, and that restriction is a condition of sale rather than a formality. Compounds in this category are not FDA-approved drugs. Buyers are expected to be researchers or laboratories handling material under appropriate institutional controls, and regulatory status varies between jurisdictions, so local rules should be confirmed before procurement.

Cost varies widely by compound, synthesis difficulty, batch size and the depth of analytical testing a supplier runs. Longer or more complex sequences cost more to synthesize, and suppliers that commission third-party HPLC, mass spectrometry and net peptide content analysis per batch carry testing costs that show up in pricing. The cheapest listing in a comparison is frequently the one carrying the least documentation.

No. Real Peptides supplies research-use-only compounds and does not provide preparation, administration or handling instructions of that kind. The only framework we discuss is concentration, expressed as milligrams per millilitre, which a researcher reads from the vial content stated on the certificate of analysis. All experimental parameters are the responsibility of the qualified laboratory running the work.

HPLC purity is an area percentage of the chromatogram showing how much of the detectable material is the main peak. Net peptide content, determined by amino acid analysis or nitrogen determination, states how much of the vial mass is actually peptide. A lyophilized vial can read 99% pure by HPLC while still containing water and residual counterions such as trifluoroacetate, so the two figures answer different questions.

Peptides degrade in solution through hydrolysis of the peptide backbone, oxidation of methionine and cysteine residues, and deamidation of asparagine and glutamine, all of which accelerate with temperature and water presence. Lyophilization removes the water, and research peptides are typically held at -20°C before reconstitution and between 2°C and 8°C afterwards. Small molecules in carrier solvent lack those vulnerable residues and tolerate ambient transit.

No. Real Peptides is not affiliated with Chemyo, and this review uses the company name nominatively to discuss publicly available information from its own site as of October 2026. Real Peptides supplies small-batch synthesized research peptides with publicly verifiable certificates of analysis, sold for laboratory research use only and not for human consumption.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA